Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

PURPOSE: Paclitaxel-based chemotherapy continues to be an integral component of breast cancer treatment. Prolonged use of paclitaxel may result in repeated doses of premedications that can have unwanted side effects. Infusion hypersensitivity reactions occurring beyond the second dose of paclitaxel...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Support Care Cancer
Main Authors: Berger, Michael J., Vargo, Craig, Vincent, Mary, Shaver, Katy, Phillips, Gary, Layman, Rachel, Macrae, Erin, Mrozek, Ewa, Ramaswamy, Bhuvaneswari, Wesolowski, Robert, Shapiro, Charles L., Lustberg, Maryam B.
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4804339/
https://ncbi.nlm.nih.gov/pubmed/25519756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2556-x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker